mobility and small size. It could directly contact with the surface of the brain. The imaging technique used in this experiment was coded phase-inversion (CPI) harmonic ultrasound, randomly configured by Alokaα-10, whose ultrasonic output power was of a low mechanical index (MI: 0.10 -0.12).
Ultrasound contrast agent was SonoVue (Bracco), which were microbubbles of the phospholipids microencapsulated sulfur hexafluoride (SF 6 ). The average diameter of the microbubble was 2.5 µm and its pH value ranged from 4.5 to 7.5. Each agent contained 59 mg of sulfur hexafluoride gas and 25 mg of lyophilized powder. SF 6 microbubbles suspension was prepared before the contrast by injecting 5 ml of sodium chloride into 59 mg of SonoVue.
Scanning methods
The craniotomy was located by referring to the preoperative MRI and/or computed tomography (CT) imaging data. The ultrasound was used to locate the lesions after opening the bone flap and cutting the endocranium of the patient.
The probe was applied with the coupling agents on its surface and protected by sterile plastic sleeve cover. It moved on the cerebral cortex to observe the tumor location, borders, shape, internal echo, its relationship with the surrounding edematous brain tissue and normal brain tissue, and to measure the lesion size and its depth to the surface of brain. The color Doppler flow imaging (CDFI) was used to observe the signal features of the peripheral and internal blood flow of lesions. Then the ultrasound contrast screen was cut into after the best lesion facet was selected. Put the observation target on the screen center, adjusting the depth and focus, starting the coding ultrasound contrast harmonic function, and setting the MI to 0.10 -0.12. Five milliliter of microbubble sulfur hexafluoride suspension was bolus injected via the femoral vein and then 10 ml of saline was injected for washing, followed by injection of the contrast agent while starting the built-in timer of the ultrasound scanner to make real-time dynamic observation of tumor blood flow perfusion and its enhanced features and to record all the image data for storage. The ultrasound scanning should be operated by neurosurgeons, which had accepted certain ultrasound technology training and had intraoperative ultrasound experience for more than 1 year. The identification of ultrasonic images should be done by ultrasound physicians with extensive experience in intraoperative ultrasound. The intraoperative ultrasound contrast operation was completed by the same doctor and the injection of the ultrasound contrast agent was also carried out by the same nurse.
Sampling methods
After the neurosurgeon judged that the tumor was totally removed, a complete hemostasis was carried out and then the cotton pieces and hemostatic materials were removed from the residue cavity. After washing repeatedly, the residual cavity was filled with saline and another ultrasound contrast was carried out on the patient. Following the procedure mentioned above, determining whether there was any residual tumor after the surgery by scanning the residual tumor cavity and its adjacentbrain surface. Biopsy was taken on the three randomly-selected points inside three tumor cavity walls, respectively, and then marked on their corresponding ultrasonic images; when there was any tumor residue detected by the ultrasound contrast, threebiopsy points would be taken on the surface of tumor residue and labeling would be done on their corresponding ultrasound images.
Examination results
The examination results were positive if there was any abnormally high-enhanced region of contrast agent inside the cavity wall, in the form of pellet or ribbon, with the thickness ≥5 mm, detected by ultrasound contrast examination and it would be suspected as tumor residue; if there was no abnormally high-enhanced region which was in the form of pellet or ribbon (thickness < 5 mm), then the results were negative. All the intraoperative biopsies were sent to the electron microscopy room to receive transmission electron microscopy examination.
The specimens for TEM sampling, fixed with 2.5% glutaraldehyde under the temperature of 4°C for 2 hours, were dehydrated in a graded ethanol and routinely embedded by epoxy resin 812. Ultrathin section was carried out after the semi-thin slice positioning. The TEM observation was taken after the uranyl acetate-lead citrate double staining.
Evaluation on the sensitivity and specificity of ultrasound contrast in detecting the tumor residues
Cases diagnosed simultaneously by sensitivity = gold standard (TEM examination) and the new diagnosis method (intraoperative ultrasound contrast) as positive/cases diagnosed by gold standard as positive. Cases diagnosed simultaneously by sensitivity = gold standard (TEM examination) and the new diagnosis method (intraoperative ultrasound contrast) as negative/cases diagnosed by gold standard as negative.
Results

TEM observation results
The common features of the astrocytoma tumor cells were as followed: chromatin inside the nucleus was evenly distributed and there were glial filaments of varying amounts inside the cytoplasm and cell protrusion, including hairy cell type and endomorphytype tumor cells [ Figure 1 ]; the nucleus of glioblastoma tumor cells were large but irregular. Its nuclear membrane was in the shape of invaginated serrate and multicores, megakaryocytes, weird nucleus tumor cells, and intranuclear pseudoinclusion could be commonly seen inside the membrane. There were many unevenly distributed heterochromatin and the inter chromatin granules with reticular or rod-shaped prominent nucleoli or multiple nucleoli could also be seen [ Figure 2 ].
There were altogether 360 samples in this operation and 87 tumor residues detected by the intraoperative ultrasound imaging [ Figure 3 ], 69 residues of which were verified by the TEM examination. The sensitivity of ultrasound contrast was 69/111 = 62.2%. There were 273 samples real-time intraoperative judgment of tumor resection degree is a major problem bothering neurosurgery. [4] Intraoperative color ultrasound scanning, whose utilization rate is of growing popularity, is simple and convenient, without tumor residues detected by intraoperative ultrasound contrast [ Figure 4 ], 231 of which were verified by the TEM examination. The specificity of ultrasound contrast was 231/249 = 92.8%. The comparison and contrast of the results obtained, respectively, by ultrasound contrast and TEM examination are shown in [ Table 1 ].
The consistency coefficient of ultrasound contrast diagnosis and TEM examination results was 0.584 (Kappa = 0.584, 0.4-0.6), and was of medium consistency.
dIscussIon
Brain gliomais the most commonly seen malignant brain tumor, whose priority of treatment is surgery. The main purpose of surgical treatment is to maximize the removal of the tumor and to control tumor growth and recurrence, while preserving normal nerve function in order to improve patients' quality of life. [1, 2] The most important determinant of the postoperative reoccurrence and clinical prognosis is the extent of glioma resection. [3] However, brain glioma grows invasively in the brain, with no obvious boundaries from normal brain tissues; therefore, it was difficult to completely remove it by surgical excision. In this aspect, The banded medium-strong echo area and its surrounding normal brain tissue examined by ultrasound contrast showed homogeneous enhancement (marked by the triangle in the Figure) . It was not considered as tumor residue by ultrasound contrast, while was proved to be gliocyteproliferation by postoperative TEM examination. real-time, and accurate. It is easy to operate and can be applied repeatedly. [5] However, there are some errors for general ultrasound contrast to identify tumor boundaries and to distinguish the edematous brain tissue surrounding the tumor from the normal brain tissue. [6] In recent years, the application of ultrasound contrast agent makes up for the flaws of general ultrasound contrast by showing the tumor location and boundaries more clearly after contrast enhancement. [7] He et al., [8] found that the application of ultrasound contrast in brain tumor could accurately and immediately locate the tumor and display the relationship between the internal blood vessels and peripheral blood vessels. Because the blood supply pattern of tumor is different from the one of normal brain tissue surrounding it, the ultrasound contrast has huge advantage in displaying the brain tumor boundaries over the ordinary intraoperative ultrasound, while displaying the tumor blood vessels. [9] It is of strong specificity and sensitivity and can determine whether there are tumor residues or not, according to the changes of local enhancement. [10] Electron microscopy technology is of significant value in terms of diagnosis and differentiation of brain glioma, by observing the ultrastructure of tissue in the micron level. [11, 12] Electron microscopy, light microscopy, and immunohistochemistry can complement each other's function in diagnosis, treatment, basic research, and prognosis prediction of brain glioma. [13] The available data would be limited, if solely relying on light microscopy and immunohistochemistry, therefore the assist of electron microscopy is necessary. [14] There are some reports on the ultrastructure of primary intracranial tumors; domestic and overseas. [15] It played an important role in promoting the diagnosis and differential diagnosis of brain tumors. [16] Transmission electron microscopy can be used as an auxiliary tool of the pathological diagnosis and differential diagnosis of brain glioma. [17] To study on the specificity and sensitivity of intraoperative ultrasound contrast, 120 patients were selected and imaging diagnosed as brain glioma by preoperative MRI scanning and enhanced examinations. Three places of tissue surrounding the residual tumor cavity after resection were taken for biopsy and 360 samples (120 × 3) were detected by biopsy. In this study, the intraoperative ultrasound contrast is of high sensitivity and specific in detecting the tumor residues. The application of it can improve the removal rate of brain glioma. The consistency coefficient is 0.584 (kappa = 0.584), which is less than 0.6. In this aspect, it is of medium instead of high consistency (0.6 -0.8), which indicates that nowadays ultrasound contrast cannot improve the brain glioma removal rate significantly.
No abnormally high-enhanced region or banded-enhanced region were clearly displayed by ultrasound contrast examinations; or there were some display of the regions but with the thickness <5 mm in 42 cases, results of which could be regarded as negative. But these specimens were proved to be tumor residues by TEM examination. In this aspect, the result obtained by the ultrasound contrast was false negative. The misdiagnosis rate was 42/231 = 16%. The edema regions surrounding the tumor showed a strong echo under the ultrasound contrast, which was easily to be regarded as false negative. The preoperative MRI could be combined to test the tumor peripheral edema regions.
There were 18 cases of false-positive biopsy verified by TEM examination as gliosis proliferation. In high malignant gliomas, gliosis proliferation regions could be seen between the tumor tissues and edema regions, which were caused by gliosis proliferation of tumor peripheraltissues. The intraoperative ultrasound contrast of the gliosis proliferation region showed medium-high echo and the one of partial thrombosis also showed strong echo. It would be mistaken as residual tumor, if the physician did not take fully consideration. [18, 19] However, it can be found that there were boundaries between the gliosis proliferation regions and tumor tissue and the echo was homogeneous by careful observation. In addition, in patients with reoccurring glioma after radiation therapy, the recurrent tumor focus, radioactive necrotic tissues, and peripheral edema tissues all showed medium-strong echo and there were no obvious boundaries between them, both of which made it difficult to identify the tumor removal degree. [20, 21] In this study, there were 12 in 18 false-positive cases of recurrent glioma which were treated with radiotherapy. Therefore, it is believed that the application of intraoperative ultrasound contrast will be limited in evaluating the tumor removal degree of patients with recurrent gliomas or patients with gliomas after radiotherapy.
In conclusion, intraoperative ultrasound contrast is simple and convenient, immediate and accurate, noninvasive and safe, and economic and affordable. It is of a high sensitivity and specificity in detecting the intraoperative tumor residues. The diagnosing results of intraoperative ultrasound contrast and postoperative TEM diagnosis are of medium consistency. The application of intraoperative ultrasound contrast can improve brain glioma removal rate. It is believed in the near future that with the continuous improvement of intraoperative ultrasound imaging techniques, the intraoperative ultrasound contrast will be applied more widely in neurosurgery.
